574 reports of this reaction
3.0% of all DEXAMETHASONE SODIUM PHOSPHATE reports
#2 most reported adverse reaction
NAUSEA is the #2 most commonly reported adverse reaction for DEXAMETHASONE SODIUM PHOSPHATE, manufactured by Amneal Pharmaceuticals LLC. There are 574 FDA adverse event reports linking DEXAMETHASONE SODIUM PHOSPHATE to NAUSEA. This represents approximately 3.0% of all 19,106 adverse event reports for this drug.
Patients taking DEXAMETHASONE SODIUM PHOSPHATE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is a less commonly reported adverse event for DEXAMETHASONE SODIUM PHOSPHATE, but still significant enough to appear in the safety profile.
In addition to nausea, the following adverse reactions have been reported for DEXAMETHASONE SODIUM PHOSPHATE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 574 FDA reports for DEXAMETHASONE SODIUM PHOSPHATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 3.0% of all adverse event reports for DEXAMETHASONE SODIUM PHOSPHATE, making it one of the most commonly reported side effect.
If you experience nausea while taking DEXAMETHASONE SODIUM PHOSPHATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.